Thomas Wadden - Publications

Affiliations: 
Obesity Center University of Pennsylvania School of Medicine, Philadelphia, PA, United States 

306 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Chao AM, Taylor S, Moore M, Amaro A, Wadden TA. Evolving Approaches for Pharmacological Therapy of Obesity. Annual Review of Pharmacology and Toxicology. PMID 39348522 DOI: 10.1146/annurev-pharmtox-031124-101146  0.385
2024 Sheynblyum M, Wadden TA, Latner JD, Pearl RL. Longitudinal associations of internalized weight stigma with physical activity and weight loss. Obesity Science & Practice. 10: e773. PMID 38966255 DOI: 10.1002/osp4.773  0.329
2024 Chao AM, Moore M, Wadden TA. The past, present, and future of behavioral obesity treatment. International Journal of Obesity (2005). PMID 38678143 DOI: 10.1038/s41366-024-01525-3  0.409
2023 Pearl RL, Hernandez M, Bach C, Groshon L, Wadden TA. Prevalence of diagnosed psychiatric disorders among adults who have experienced and internalized weight stigma. Obesity Science & Practice. 9: 681-687. PMID 38090681 DOI: 10.1002/osp4.700  0.32
2023 Chao AM, Wadden TA, Cao W, Zhou Y, Maldonado D, Cardel MI, Foster GD, Loughead J. Randomized Controlled Trial of Effects of Behavioral Weight Loss Treatment on Food Cue Reactivity. Nursing Research. PMID 37916843 DOI: 10.1097/NNR.0000000000000702  0.607
2023 Wadden TA, Chao AM, Machineni S, Kushner R, Ard J, Srivastava G, Halpern B, Zhang S, Chen J, Bunck MC, Ahmad NN, Forrester T. Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial. Nature Medicine. PMID 37840095 DOI: 10.1038/s41591-023-02597-w  0.382
2023 Grunstein RR, Wadden TA, Chapman JL, Malhotra A, Phillips CL. Giving weight to incretin-based pharmacotherapy for obesity-related sleep apnea: a revolution or a pipe dream? Sleep. 46. PMID 37668448 DOI: 10.1093/sleep/zsad224  0.44
2023 Chao AM, Zhou Y, Erus G, Davatzikos C, Cardel MI, Foster GD, Wadden TA. A randomized controlled trial examining the effects of behavioral weight loss treatment on hippocampal volume and neurocognition. Physiology & Behavior. 267: 114228. PMID 37156318 DOI: 10.1016/j.physbeh.2023.114228  0.67
2023 Pearl RL, Wadden TA, Bach C, LaFata EM, Gautam S, Leonard S, Berkowitz RI, Latner JD, Jakicic JM. Long-term effects of an internalized weight stigma intervention: A randomized controlled trial. Journal of Consulting and Clinical Psychology. PMID 37155264 DOI: 10.1037/ccp0000819  0.322
2023 Allison KC, Wu J, Spitzer JC, McCuen-Wurst C, Ashare RL, Tewksbury C, LaGrotte CA, Wadden TA, Williams NN, Sarwer DB. Changes in Eating Behaviors and Their Relation to Weight Change 6 and 12 Months After Bariatric Surgery. Obesity Surgery. 1-10. PMID 36690865 DOI: 10.1007/s11695-022-06442-w  0.309
2022 Pearl RL, Bach C, Wadden TA. Development of a cognitive-behavioral intervention for internalized weight stigma. Journal of Contemporary Psychotherapy. 53: 165-172. PMID 37483684 DOI: 10.1007/s10879-022-09543-w  0.306
2022 Chao AM, Tronieri JS, Amaro A, Wadden TA. Clinical Insight on Semaglutide for Chronic Weight Management in Adults: Patient Selection and Special Considerations. Drug Design, Development and Therapy. 16: 4449-4461. PMID 36601368 DOI: 10.2147/DDDT.S365416  0.412
2022 Pearl RL, Wadden TA, Groshon LC, Fitterman-Harris HF, Bach C, LaFata EM. Refining the conceptualization and assessment of internalized weight stigma: A mixed methods approach. Body Image. 44: 93-102. PMID 36549092 DOI: 10.1016/j.bodyim.2022.12.002  0.391
2022 Wing RR, Howard MJ, Olson KL, Unick J, Chao AM, Wadden TA, Wagenknecht LE. Weight changes during COVID Shutdown in Older Individuals with Type 2 Diabetes: The Look AHEAD Study. Obesity (Silver Spring, Md.). PMID 36478643 DOI: 10.1002/oby.23674  0.437
2022 Garvey WT, Batterham RL, Bhatta M, Buscemi S, Christensen LN, Frias JP, Jódar E, Kandler K, Rigas G, Wadden TA, Wharton S. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine. 28: 2083-2091. PMID 36216945 DOI: 10.1038/s41591-022-02026-4  0.441
2022 Bruzas MB, Tronieri JS, Chao AM, Jones E, McAllister C, Gruber K, McCuen-Wurst C, Berkowitz RI, Wadden TA, Allison KC. Binge size and loss of control as correlates of eating behavior and psychopathology among individuals with binge eating disorder and higher weight. Journal of Behavioral Medicine. PMID 35449358 DOI: 10.1007/s10865-022-00312-7  0.308
2022 Wilding JPH, Batterham RL, Davies M, Van Gaal LF, Kandler K, Konakli K, Lingvay I, McGowan BM, Oral TK, Rosenstock J, Wadden TA, Wharton S, Yokote K, Kushner RF. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes, Obesity & Metabolism. PMID 35441470 DOI: 10.1111/dom.14725  0.326
2022 Wing RR, Neiberg RH, Bahnson JL, Clark JM, Espeland MA, Hill JO, Johnson KC, Knowler WC, Olson K, Steinburg H, Pi-Sunyer X, Wadden TA, Wyatt H, Clark JM, Swartz L, ... ... Wadden TA, et al. Weight Change During the Postintervention Follow-up of Look AHEAD. Diabetes Care. PMID 35421225 DOI: 10.2337/dc21-1990  0.396
2022 Rubino DM, Greenway FL, Khalid U, O'Neil PM, Rosenstock J, Sørrig R, Wadden TA, Wizert A, Garvey WT. Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial. Jama. 327: 138-150. PMID 35015037 DOI: 10.1001/jama.2021.23619  0.374
2022 Delahanty LM, Wadden TA, Goodwin PJ, Alfano CM, Thomson CA, Irwin ML, Neuhouser ML, Crane TE, Frank E, Spears PA, Gillis BP, Hershman DL, Paskett ED, Hopkins J, Bernstein V, et al. The Breast Cancer Weight Loss trial (Alliance A011401): A description and evidence for the lifestyle intervention. Obesity (Silver Spring, Md.). 30: 28-38. PMID 34932888 DOI: 10.1002/oby.23287  0.315
2021 Chao AM, Tronieri JS, Amaro A, Wadden TA. Semaglutide for the Treatment of Obesity. Trends in Cardiovascular Medicine. PMID 34942372 DOI: 10.1016/j.tcm.2021.12.008  0.446
2021 Lingvay I, Garvey WT, Wadden TA. Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy and Body Weight in Adults With Overweight or Obesity-Reply. Jama. 326: 1214-1215. PMID 34581743 DOI: 10.1001/jama.2021.13024  0.409
2021 Wharton S, Calanna S, Davies M, Dicker D, Goldman B, Lingvay I, Mosenzon O, Rubino DM, Thomsen M, Wadden TA, Pedersen SD. Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss. Diabetes, Obesity & Metabolism. PMID 34514682 DOI: 10.1111/dom.14551  0.405
2021 Gupta SR, Zhou Y, Wadden TA, Berkowitz RI, Chao AM. A Systematic Review of Genetic Correlates of Weight Loss After Bariatric Surgery. Obesity Surgery. PMID 34370160 DOI: 10.1007/s11695-021-05585-6  0.335
2021 Moustafa AF, Quigley KM, Wadden TA, Berkowitz RI, Chao AM. A systematic review of binge eating, loss of control eating, and weight loss in children and adolescents. Obesity (Silver Spring, Md.). PMID 34227229 DOI: 10.1002/oby.23185  0.326
2021 Rubino D, Abrahamsson N, Davies M, Hesse D, Greenway FL, Jensen C, Lingvay I, Mosenzon O, Rosenstock J, Rubio MA, Rudofsky G, Tadayon S, Wadden TA, Dicker D. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. Jama. PMID 33755728 DOI: 10.1001/jama.2021.3224  0.441
2021 Wadden TA, Bailey TS, Billings LK, Davies M, Frias JP, Koroleva A, Lingvay I, O'Neil PM, Rubino DM, Skovgaard D, Wallenstein SOR, Garvey WT. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial. Jama. PMID 33625476 DOI: 10.1001/jama.2021.1831  0.47
2021 Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, McGowan BM, Rosenstock J, Tran MTD, Wadden TA, Wharton S, Yokote K, Zeuthen N, Kushner RF. Once-Weekly Semaglutide in Adults with Overweight or Obesity. The New England Journal of Medicine. PMID 33567185 DOI: 10.1056/NEJMoa2032183  0.379
2021 Wharton S, Astrup A, Endahl L, Lean MEJ, Satylganova A, Skovgaard D, Wadden TA, Wilding JPH. Estimating and reporting treatment effects in clinical trials for weight management: using estimands to interpret effects of intercurrent events and missing data. International Journal of Obesity (2005). PMID 33462358 DOI: 10.1038/s41366-020-00733-x  0.311
2021 Chao AM, Quigley KM, Wadden TA. Dietary interventions for obesity: clinical and mechanistic findings. The Journal of Clinical Investigation. 131. PMID 33393504 DOI: 10.1172/JCI140065  0.413
2020 Tronieri JS, Wadden TA, Pearl RL, Berkowitz RI, Alamuddin N, Chao AM. Mindful Eating, General Mindful Awareness, and Acceptance as Predictors of Weight Loss. Mindfulness. 11: 2818-2827. PMID 33777254 DOI: 10.1007/s12671-020-01493-5  0.359
2020 Sarwer DB, Wadden TA, Ashare RL, Spitzer JC, McCuen-Wurst C, LaGrotte C, Williams NN, Edwards M, Tewksbury C, Wu J, Tajeu G, Allison KC. Psychopathology, disordered eating, and impulsivity in patients seeking bariatric surgery. Surgery For Obesity and Related Diseases : Official Journal of the American Society For Bariatric Surgery. PMID 33341423 DOI: 10.1016/j.soard.2020.11.005  0.376
2020 Tronieri JS, Fabricatore AN, Wadden TA, Auerbach P, Endahl L, Sugimoto D, Rubino D. Effects of Dietary Self-Monitoring, Physical Activity, Liraglutide 3.0 mg, and Placebo on Weight Loss in the SCALE IBT Trial. Obesity Facts. 1-12. PMID 33197917 DOI: 10.1159/000511130  0.35
2020 Pearl RL, Wadden TA, Bach C, Tronieri JS, Berkowitz RI. Six-Month Follow-up from a Randomized Controlled Trial of the Weight BIAS Program. Obesity (Silver Spring, Md.). PMID 32860344 DOI: 10.1002/oby.22931  0.333
2020 Chao AM, Wadden TA, Berkowitz RI, Quigley K, Silvestry F. The risk of cardiovascular complications with current obesity drugs. Expert Opinion On Drug Safety. PMID 32750250 DOI: 10.1080/14740338.2020.1806234  0.325
2020 Kuna ST, Reboussin DM, Strotmeyer ES, Millman RP, Zammit G, Walkup MP, Wadden TA, Wing RR, Pi-Sunyer FX, Spira AP, Foster GD. Effects of Weight Loss on Obstructive Sleep Apnea Severity: 10-year Results of the Sleep AHEAD Study. American Journal of Respiratory and Critical Care Medicine. PMID 32721163 DOI: 10.1164/Rccm.201912-2511Oc  0.603
2020 Pearl RL, Wadden TA, Bach C, Leonard SM, Michel KE. Who's a good boy? Effects of dog and owner body weight on veterinarian perceptions and treatment recommendations. International Journal of Obesity (2005). PMID 32523035 DOI: 10.1038/s41366-020-0622-7  0.417
2020 Tronieri JS, Wadden TA, Walsh O, Berkowitz RI, Alamuddin N, Chao AM. Measures of adherence as predictors of early and total weight loss with intensive behavioral therapy for obesity combined with liraglutide 3.0 mg. Behaviour Research and Therapy. 131: 103639. PMID 32450367 DOI: 10.1016/j.brat.2020.103639  0.411
2020 Kushner RF, Calanna S, Davies M, Dicker D, Garvey WT, Goldman B, Lingvay I, Thomsen M, Wadden TA, Wharton S, Wilding JPH, Rubino D. Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5. Obesity (Silver Spring, Md.). 28: 1050-1061. PMID 32441473 DOI: 10.1002/Oby.22794  0.414
2020 Chao AM, Wadden TA, Berkowitz RI, Blackburn G, Bolin P, Clark JM, Coday M, Curtis JM, Delahanty LM, Dutton GR, Evans M, Ewing LJ, Foreyt JP, Gay LJ, et al. Weight Change 2 Years After Termination of the Intensive Lifestyle Intervention in the Look AHEAD Study. Obesity (Silver Spring, Md.). 28: 893-901. PMID 32320144 DOI: 10.1002/Oby.22769  0.338
2020 Wadden TA, Tronieri JS, Sugimoto D, Lund MT, Auerbach P, Jensen C, Rubino D. Liraglutide 3.0 mg and Intensive Behavioral Therapy (IBT) for Obesity in Primary Care: The SCALE IBT Randomized Controlled Trial. Obesity (Silver Spring, Md.). 28: 529-536. PMID 32090517 DOI: 10.1002/oby.22726  0.315
2020 Wadden TA, Tronieri JS, Butryn ML. Lifestyle modification approaches for the treatment of obesity in adults. The American Psychologist. 75: 235-251. PMID 32052997 DOI: 10.1037/Amp0000517  0.451
2020 Schulte EM, Tuerk PW, Wadden TA, Garvey WT, Weiss D, Hermayer KL, Aronne LJ, Becker LE, Fujioka K, Miller-Kovach K, Kushner RF, Malcolm RJ, Raum WJ, Rost SL, Rubino DM, et al. Changes in weight control behaviors and hedonic hunger in a commercial weight management program adapted for individuals with type 2 diabetes. International Journal of Obesity (2005). PMID 31949295 DOI: 10.1038/S41366-020-0530-X  0.312
2019 Chao AM, Wadden TA, Walsh OA, Gruber KA, Alamuddin N, Berkowitz RI, Tronieri JS. Changes in health-related quality of life with intensive behavioural therapy combined with liraglutide 3.0 mg per day. Clinical Obesity. e12340. PMID 31691531 DOI: 10.1111/cob.12340  0.359
2019 Pearl RL, Himmelstein MS, Puhl RM, Wadden TA, Wojtanowski AC, Foster GD. Weight bias internalization in a commercial weight management sample: prevalence and correlates. Obesity Science & Practice. 5: 342-353. PMID 31452919 DOI: 10.1002/Osp4.354  0.636
2019 Tronieri JS, Wadden TA, Leonard SM, Berkowitz RI. A pilot study of acceptance-based behavioural weight loss for adolescents with obesity. Behavioural and Cognitive Psychotherapy. 1-11. PMID 30992093 DOI: 10.1017/S1352465819000262  0.4
2019 Tronieri JS, Wadden TA, Walsh O, Berkowitz RI, Alamuddin N, Gruber K, Leonard S, Bakizada ZM, Chao AM. Effects of liraglutide on appetite, food preoccupation, and food liking: results of a randomized controlled trial. International Journal of Obesity (2005). PMID 30926955 DOI: 10.1038/s41366-019-0348-6  0.302
2019 Tronieri JS, Wadden TA, Wals OA, Berkowitz RI, Alamuddin N, Gruber K, Leonard S, Chao AM. Metabolism: Clinical and Experimental. PMID 30902750 DOI: 10.1016/j.metabol.2019.03.005  0.383
2019 Sarwer DB, Allison KC, Wadden TA, Ashare R, Spitzer JC, McCuen-Wurst C, LaGrotte C, Williams NN, Edwards M, Tewksbury C, Wu J. Psychopathology, disordered eating, and impulsivity as predictors of outcomes of bariatric surgery. Surgery For Obesity and Related Diseases : Official Journal of the American Society For Bariatric Surgery. PMID 30858009 DOI: 10.1016/j.soard.2019.01.029  0.349
2019 Pearl RL, Wadden TA, Chao AM, Alamuddin N, Berkowitz RI, Walsh O, Allison KC, Tronieri JS. Associations between causal attributions for obesity and long-term weight loss. Behavioral Medicine (Washington, D.C.). 1-5. PMID 30657439 DOI: 10.1080/08964289.2018.1556202  0.494
2019 Shaw Tronieri J, Wadden T, Sugimoto D, Lund M, Auerbach P, Endahl L, Rubino D. SAT-105 Weight Loss As Determined By Adherence To Reduced Caloric Diet, Increased Physical Activity, Liraglutide 3.0 Mg and Placebo: A Sub-analysis Of The SCALE IBT Trial Journal of the Endocrine Society. 3. DOI: 10.1210/Js.2019-Sat-105  0.411
2019 Wadden T, Shaw Tronieri J, Sugimoto D, Lund M, Auerbach P, Jensen C, Rubino D. SAT-099 Liraglutide 3.0 mg as an Adjunct to Intensive Behavior Therapy in Individuals with Obesity: SCALE IBT 56-Week Randomized, Double-Blind, Placebo-Controlled Trial Journal of the Endocrine Society. 3. DOI: 10.1210/Js.2019-Sat-099  0.37
2019 Shaw Tronieri J, Wadden T, Sugimoto D, Lund M, Auerbach P, Endahl L, Rubino D. SAT-097 Weight Loss With Liraglutide 3.0 Mg Versus Placebo For Individuals Who Adhere To The Trial Drug: A Secondary Analysis From SCALE IBT Journal of the Endocrine Society. 3. DOI: 10.1210/Js.2019-Sat-097  0.387
2019 Rubino D, Shaw Tronieri J, Sugimoto D, Lund M, Satylganova A, Zeuthen N, Wadden T. MON-120 Effect of Weight Loss on Physical Function Measured by the 6-Minute Walking Distance Test in Individuals with Obesity: Results from the SCALE IBT Trial of Liraglutide 3.0 Mg Journal of the Endocrine Society. 3. DOI: 10.1210/Js.2019-Mon-120  0.483
2019 Kuna S, Reboussin D, Wojtanowski A, Sifferman A, Strotmeyer E, Millman R, Zammit G, Walkup M, Jakicic J, Newman A, Wadden T, Wing R, Pi-Sunyer F, Foster G. Long term effects of weight loss on obstructive sleep apnea in adults with type 2 diabetes and overweight/obesity: 10-year results of the sleep ahead study Sleep Medicine. 64: S206. DOI: 10.1016/J.Sleep.2019.11.575  0.643
2018 Walsh OA, Wadden TA, Tronieri JS, Chao AM, Pearl RL. Weight Bias Internalization Is Negatively Associated With Weight-Related Quality of Life in Persons Seeking Weight Loss. Frontiers in Psychology. 9: 2576. PMID 30618992 DOI: 10.3389/fpsyg.2018.02576  0.405
2018 Wadden TA, Walsh OA, Berkowitz RI, Chao AM, Alamuddin N, Gruber K, Leonard S, Mugler K, Bakizada Z, Tronieri JS. Intensive Behavioral Therapy for Obesity Combined with Liraglutide 3.0 mg: A Randomized Controlled Trial. Obesity (Silver Spring, Md.). PMID 30421856 DOI: 10.1002/oby.22359  0.321
2018 Chao AM, Wadden TA, Tronieri JS, Berkowitz RI. Alcohol Intake and Weight Loss During Intensive Lifestyle Intervention for Adults with Overweight or Obesity and Diabetes. Obesity (Silver Spring, Md.). PMID 30421851 DOI: 10.1002/oby.22316  0.34
2018 Pearl RL, Wadden TA, Chao AM, Walsh O, Alamuddin N, Berkowitz RI, Tronieri JS. Weight Bias Internalization and Long-Term Weight Loss in Patients With Obesity. Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine. PMID 30304382 DOI: 10.1093/abm/kay084  0.431
2018 Pearl RL, Wadden TA, Allison KC, Chao AM, Alamuddin N, Berkowitz RI, Walsh O, Tronieri JS. Causal Attributions for Obesity Among Patients Seeking Surgical Versus Behavioral/Pharmacological Weight Loss Treatment. Obesity Surgery. PMID 30191502 DOI: 10.1007/s11695-018-3490-7  0.365
2018 Kumanyika SK, Morales KH, Allison KC, Russell Localio A, Sarwer DB, Phipps E, Fassbender JE, Tsai AG, Wadden TA. Two-Year Results of Think Health! ¡Vive Saludable!: A Primary Care Weight-Management Trial. Obesity (Silver Spring, Md.). PMID 30160061 DOI: 10.1002/oby.22258  0.303
2018 Tronieri JS, Wadden TA, Alfaris N, Chao AM, Alamuddin N, Berkowitz RI, Pearl RL. "Last Supper" Predicts Greater Weight Loss Early in Obesity Treatment, but Not Enough to Offset Initial Gains. Frontiers in Psychology. 9: 1335. PMID 30116212 DOI: 10.3389/fpsyg.2018.01335  0.452
2018 Chao AM, Wadden TA, Tronieri JS, Pearl RL, Alamuddin N, Bakizada ZM, Pinkasavage E, Leonard SM, Alfaris N, Berkowitz RI. Effects of addictive-like eating behaviors on weight loss with behavioral obesity treatment. Journal of Behavioral Medicine. PMID 30066187 DOI: 10.1007/s10865-018-9958-z  0.332
2018 Tronieri JS, Wadden TA, Chao AM, Pearl RL, Alamuddin N, Berkowitz RI. Early Weight Loss in Behavioral Treatment Predicts Later Rate of Weight Loss and Response to Pharmacotherapy. Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine. PMID 29800080 DOI: 10.1093/abm/kay036  0.347
2018 Pearl RL, Wadden TA. Weight Stigma Affects Men Too. Obesity (Silver Spring, Md.). PMID 29722473 DOI: 10.1002/oby.22205  0.332
2018 Pearl RL, Wadden TA, Tronieri JS, Berkowitz RI, Chao AM, Alamuddin N, Leonard SM, Carvajal R, Bakizada ZM, Pinkasavage E, Gruber KA, Walsh OA, Alfaris N. Short- and Long-Term Changes in Health-Related Quality of Life with Weight Loss: Results from a Randomized Controlled Trial. Obesity (Silver Spring, Md.). PMID 29676530 DOI: 10.1002/oby.22187  0.328
2018 Bray GA, Heisel WE, Afshin A, Jensen MD, Dietz WH, Long M, Kushner RF, Daniels SR, Wadden TA, Tsai AG, Hu FB, Jakicic JM, Ryan DH, Wolfe BM, Inge TH. The Science of Obesity Management: An Endocrine Society Scientific Statement. Endocrine Reviews. PMID 29518206 DOI: 10.1210/Er.2017-00253  0.475
2018 Chao AM, Wadden TA, Berkowitz RI. The safety of pharmacologic treatment for pediatric obesity. Expert Opinion On Drug Safety. 1-7. PMID 29411652 DOI: 10.1080/14740338.2018.1437143  0.355
2018 Tsai AG, Remmert JE, Butryn ML, Wadden TA. Treatment of Obesity in Primary Care. The Medical Clinics of North America. 102: 35-47. PMID 29156186 DOI: 10.1016/J.Mcna.2017.08.005  0.35
2018 Ligibel JA, Barry WT, Alfano CM, Hershman DL, Irwin ML, Neuhouser M, Thomson CA, Delahanty L, Frank E, Spears P, Paskett ED, Hopkins JO, Bernstein V, Stearns V, White JR, ... Wadden T, et al. The Breast Cancer Weight Loss (BWEL) trial: Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early-stage breast cancer (Alliance A011401). Journal of Clinical Oncology. 36. DOI: 10.1200/Jco.2018.36.15_Suppl.Tps598  0.412
2018 Tronieri JS, Wadden TA, Pearl R, Allison KC, Walsh O, Williams NN. Differences in Psychosocial Status and Predisposition to Obesity by BMI Class and Type of Treatment Surgery For Obesity and Related Diseases. 14: S143. DOI: 10.1016/j.soard.2018.09.320  0.329
2017 Shaw Tronieri J, Wadden TA, Berkowitz RI, Chao AM, Pearl RL, Alamuddin N, Leonard SM, Carvajal R, Bakizada ZM, Pinkasavage E, Gruber KA, Walsh OA, Alfaris N. A Randomized Trial of Lorcaserin and Lifestyle Counseling for Maintaining Weight Loss Achieved with a Low-Calorie Diet. Obesity (Silver Spring, Md.). PMID 29288545 DOI: 10.1002/oby.22081  0.365
2017 Pearl RL, Wadden TA, Tronieri JS, Chao AM, Alamuddin N, Berkowitz RI. Everyday discrimination in a racially diverse sample of patients with obesity. Clinical Obesity. PMID 29266824 DOI: 10.1111/cob.12235  0.378
2017 Chao AM, Wadden TA, Gorin AA, Shaw Tronieri J, Pearl RL, Bakizada ZM, Yanovski SZ, Berkowitz RI. Binge Eating and Weight Loss Outcomes in Individuals with Type 2 Diabetes: 4-Year Results from the Look AHEAD Study. Obesity (Silver Spring, Md.). 25: 1830-1837. PMID 29086498 DOI: 10.1002/Oby.21975  0.422
2017 Ligibel JA, Barry WT, Alfano C, Hershman DL, Irwin M, Neuhouser M, Thomson CA, Delahanty L, Frank E, Spears P, Paskett ED, Hopkins J, Bernstein V, Stearns V, White J, ... ... Wadden TA, et al. Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): study design. Npj Breast Cancer. 3: 37. PMID 28948213 DOI: 10.1038/s41523-017-0040-8  0.353
2017 Johnson KC, Bray GA, Cheskin LJ, Clark JM, Egan CM, Foreyt JP, Garcia KR, Glasser S, Greenway FL, Gregg EW, Hazuda HP, Hergenroeder A, Hill JO, Horton ES, Jakicic JM, ... ... Wadden TA, et al. The effect of intentional weight loss on fracture risk in persons with diabetes: results from the Look AHEAD Randomized Clinical Trial. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 28678345 DOI: 10.1002/Jbmr.3214  0.302
2017 Kahan S, Cuker A, Kushner RF, Maahs J, Recht M, Wadden T, Willis T, Majumdar S, Ungar D, Cooper D. Prevalence and impact of obesity in people with haemophilia: Review of literature and expert discussion around implementing weight management guidelines. Haemophilia : the Official Journal of the World Federation of Hemophilia. PMID 28636076 DOI: 10.1111/Hae.13291  0.526
2017 Tronieri JS, Alfaris N, Chao AM, Pearl RL, Alamuddin N, Bakizada ZM, Berkowitz RI, Wadden TA. Lorcaserin plus lifestyle modification for weight loss maintenance: Rationale and design for a randomized controlled trial. Contemporary Clinical Trials. PMID 28600158 DOI: 10.1016/j.cct.2017.06.004  0.387
2017 Shechter A, Foster GD, Lang W, Reboussin DM, St-Onge MP, Zammit G, Newman AB, Millman RP, Wadden TA, Jakicic JM, Strotmeyer ES, Wing RR, Pi-Sunyer FX, Kuna ST. Effects of a lifestyle intervention on REM sleep-related OSA severity in obese individuals with type 2 diabetes. Journal of Sleep Research. PMID 28560832 DOI: 10.1111/Jsr.12559  0.637
2017 Pearl RL, Argueso D, Wadden TA. Effects of medical trainees' weight-loss history on perceptions of patients with obesity. Medical Education. PMID 28497511 DOI: 10.1111/medu.13275  0.408
2017 Semla TP, Ruser C, Good CB, Yanovski SZ, Ames D, Copeland LA, Billington C, Ferguson UI, Aronne LJ, Wadden TA, Garvey WT, Apovian CM, Atkins D. Pharmacotherapy for Weight Management in the VHA. Journal of General Internal Medicine. PMID 28271432 DOI: 10.1007/S11606-016-3949-Y  0.327
2017 Webb VL, Wadden TA. Intensive Lifestyle Intervention for Obesity: Principles, Practices, and Results. Gastroenterology. PMID 28192109 DOI: 10.1053/j.gastro.2017.01.045  0.423
2017 Pearl RL, Wadden TA, Hopkins CM, Shaw JA, Hayes MR, Bakizada ZM, Alfaris N, Chao AM, Pinkasavage E, Berkowitz RI, Alamuddin N. Association between weight bias internalization and metabolic syndrome among treatment-seeking individuals with obesity. Obesity (Silver Spring, Md.). 25: 317-322. PMID 28124502 DOI: 10.1002/Oby.21716  0.401
2017 Rapp SR, Carmichael OT, Hayden KM, Neiberg RH, Newman AB, Keller JN, Wadden T, Hill JO, Horton ES, Johnson KC, Wagenknecht LE, Wing RR, Espeland MA. Long-Term Impact Of Weight Loss Intervention On Changes In Cognitive Function: Exploratory Analyses From The Action For Health In Diabetes Randomized Controlled Clinical Trial Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.1242  0.355
2016 Brownell KD, Wadden TA. The Heterogeneity of Obesity: Fitting Treatments To Individuals - Republished Article. Behavior Therapy. 47: 950-965. PMID 27993343 DOI: 10.1016/j.beth.2016.11.009  0.333
2016 Alamuddin N, Bakizada Z, Wadden TA. Management of Obesity. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 34: 4295-4305. PMID 27903153 DOI: 10.1200/JCO.2016.66.8806  0.466
2016 O'Neil PM, Miller-Kovach K, Tuerk PW, Becker LE, Wadden TA, Fujioka K, Hollander PL, Kushner RF, Timothy Garvey W, Rubino DM, Malcolm RJ, Weiss D, Raum WJ, Salyer JL, Hermayer KL, et al. Randomized controlled trial of a nationally available weight control program tailored for adults with type 2 diabetes. Obesity (Silver Spring, Md.). 24: 2269-2277. PMID 27804264 DOI: 10.1002/Oby.21616  0.32
2016 Pearl RL, Hopkins CH, Berkowitz RI, Wadden TA. Group cognitive-behavioral treatment for internalized weight stigma: a pilot study. Eating and Weight Disorders : Ewd. PMID 27787772 DOI: 10.1007/s40519-016-0336-y  0.323
2016 Wadden TA, Berkowitz RI. Advancing the revolution in the behavioral treatment of obesity. Obesity (Silver Spring, Md.). 24: 2029-30. PMID 27670398 DOI: 10.1002/oby.21641  0.304
2016 Alamuddin N, Wadden TA. Behavioral Treatment of the Patient with Obesity. Endocrinology and Metabolism Clinics of North America. 45: 565-80. PMID 27519131 DOI: 10.1016/j.ecl.2016.04.008  0.447
2016 Wing RR, Espeland MA, Clark, Hazuda HP, Knowler WC, Pownall, Unick, Wadden T, Wagenknecht. Association of Weight Loss Maintenance and Weight Regain on 4-Year Changes in CVD Risk Factors: the Action for Health in Diabetes (Look AHEAD) Clinical Trial. Diabetes Care. 39: 1345-55. PMID 27271190 DOI: 10.2337/Dc16-0509  0.479
2016 Blackman A, Foster GD, Zammit G, Rosenberg R, Aronne L, Wadden T, Claudius B, Jensen CB, Mignot E. Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial. International Journal of Obesity (2005). PMID 27005405 DOI: 10.1038/Ijo.2016.52  0.666
2016 Nissen SE, Wolski KE, Prcela L, Wadden T, Buse JB, Bakris G, Perez A, Smith SR. Effect of Naltrexone-Bupropion on Major Adverse Cardiovascular Events in Overweight and Obese Patients With Cardiovascular Risk Factors: A Randomized Clinical Trial. Jama. 315: 990-1004. PMID 26954408 DOI: 10.1001/Jama.2016.1558  0.407
2016 Allison KC, Lundgren JD, Wadden TA. Albert J. Stunkard: His Research on Obesity and Its Psychological Impact. Current Obesity Reports. PMID 26820621 DOI: 10.1007/S13679-016-0199-6  0.332
2015 Kline CE, Reboussin DM, Foster GD, Rice TB, Strotmeyer ES, Jakicic JM, Millman RP, Pi-Sunyer FX, Newman AB, Wadden TA, Zammit G, Kuna ST. The Effect of Changes in Cardiorespiratory Fitness and Weight on Obstructive Sleep Apnea Severity in Overweight Adults with Type 2 Diabetes. Sleep. PMID 26446118 DOI: 10.5665/Sleep.5436  0.649
2015 Tsai AG, Felton S, Wadden TA, Hosokawa PW, Hill JO. A randomized clinical trial of a weight loss maintenance intervention in a primary care population. Obesity (Silver Spring, Md.). 23: 2015-21. PMID 26334108 DOI: 10.1002/oby.21224  0.367
2015 Alfaris N, Minnick AM, Hopkins CM, Berkowitz RI, Wadden TA. Combination phentermine and topiramate extended release in the management of obesity. Expert Opinion On Pharmacotherapy. 16: 1263-74. PMID 25958964 DOI: 10.1517/14656566.2015.1041505  0.389
2015 Ochner CN, Tsai AG, Kushner RF, Wadden TA. Treating obesity seriously: when recommendations for lifestyle change confront biological adaptations. The Lancet. Diabetes & Endocrinology. 3: 232-4. PMID 25682354 DOI: 10.1016/S2213-8587(15)00009-1  0.32
2015 Alfaris N, Wadden TA, Sarwer DB, Diwald L, Volger S, Hong P, Baxely A, Minnick AM, Vetter ML, Berkowitz RI, Chittams J. Effects of a 2-year behavioral weight loss intervention on sleep and mood in obese individuals treated in primary care practice. Obesity (Silver Spring, Md.). 23: 558-64. PMID 25611944 DOI: 10.1002/oby.20996  0.45
2015 Yanovski SZ, Marcus MD, Wadden TA, Walsh BT. The Questionnaire on Eating and Weight Patterns-5: an updated screening instrument for binge eating disorder. The International Journal of Eating Disorders. 48: 259-61. PMID 25545458 DOI: 10.1002/Eat.22372  0.366
2015 Bray GA, Wadden TA. Improving long-term weight loss maintenance: can we do it? Obesity (Silver Spring, Md.). 23: 2-3. PMID 25504330 DOI: 10.1002/oby.20964  0.306
2015 Wadden TA, Hollander P, Klein S, Niswender K, Woo V, Hale PM, Aronne L. Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: The SCALE Maintenance randomized study. International Journal of Obesity (2005). 39: 187. PMID 25311036 DOI: 10.1038/ijo.2014.88  0.413
2015 Phipps E, Chacko L, Fassbender J, Allison K, Sarwer D, Wallace S, Tan-Torres S, Bowman MA, Wadden T, Kumanyika S. Provider Views of the Feasibility and Utility of Lifestyle Obesity Treatment in Primary Care: Insights from the Think Health! Study European Journal For Person Centered Healthcare. 3: 77-82. DOI: 10.5750/Ejpch.V3I1.878  0.433
2015 Blackman A, Foster G, Rosenberg R, Aronne L, Wadden T, Claudius B, Jensen C, Zammit G. Improvements in sleep apnea endpoints and quality of life are related to the degree of weight loss: Results from the randomized, double-blind scale sleep apnea trial Sleep Medicine. 16: S211-S212. DOI: 10.1016/J.Sleep.2015.02.1442  0.623
2015 Blackman A, Foster G, Zammit G, Rosenberg R, Aronne L, Wadden T, Claudius B, Jensen C, Mignot E. Liraglutide 3.0 mg reduces severity of obstructive sleep apnea and body weight in obese individuals with moderate or severe disease: scale sleep apnoea tria Sleep Medicine. 16: S24. DOI: 10.1016/J.Sleep.2015.02.058  0.667
2015 Blackman A, Foster G, Zammit G, Rosenberg R, Wadden T, Aronne L, Donsmark M, Boras D. Liraglutide 3.0 mg Reduces Severity of Obstructive Sleep Apnea and Body Weight in Individuals with Obesity and Moderate or Severe Disease: SCALE Sleep Apnoea Trial Canadian Journal of Diabetes. 39: S35. DOI: 10.1016/J.Jcjd.2015.01.139  0.644
2014 Shechter A, St-Onge MP, Kuna ST, Zammit G, RoyChoudhury A, Newman AB, Millman RP, Reboussin DM, Wadden TA, Jakicic JM, Pi-Sunyer FX, Wing RR, Foster GD. Sleep architecture following a weight loss intervention in overweight and obese patients with obstructive sleep apnea and type 2 diabetes: relationship to apnea-hypopnea index. Journal of Clinical Sleep Medicine : Jcsm : Official Publication of the American Academy of Sleep Medicine. 10: 1205-11. PMID 25325608 DOI: 10.5664/Jcsm.4202  0.644
2014 Morales KH, Kumanyika SK, Fassbender JE, Good J, Localio AR, Wadden TA. Patterns of weight change in black Americans: Pooled analysis from three behavioral weight loss trials Obesity. 22: 2632-2640. PMID 25251464 DOI: 10.1002/oby.20904  0.423
2014 Allison KC, Berkowitz RI, Brownell KD, Foster GD, Wadden TA. Albert J. ("Mickey") Stunkard, M.D. Obesity (Silver Spring, Md.). 22: 1937-8. PMID 25164258 DOI: 10.1002/Oby.20869  0.468
2014 Chirinos JA, Gurubhagavatula I, Teff K, Rader DJ, Wadden TA, Townsend R, Foster GD, Maislin G, Saif H, Broderick P, Chittams J, Hanlon AL, Pack AI. CPAP, weight loss, or both for obstructive sleep apnea. The New England Journal of Medicine. 370: 2265-75. PMID 24918371 DOI: 10.1056/Nejmoa1306187  0.647
2014 Tsai AG, Fabricatore AN, Wadden TA, Higginbotham AJ, Anderson A, Foreyt J, Hill JO, Jeffery RW, Gluck ME, Lipkin EW, Reeves RS, Van Dorsten B. Readiness redefined: a behavioral task during screening predicted 1-year weight loss in the look AHEAD study. Obesity (Silver Spring, Md.). 22: 1016-23. PMID 24151217 DOI: 10.1002/Oby.20648  0.306
2014 Lent MR, Eichen DM, Goldbacher E, Wadden TA, Foster GD. Relationship of food addiction to weight loss and attrition during obesity treatment. Obesity (Silver Spring, Md.). 22: 52-5. PMID 23776067 DOI: 10.1002/Oby.20512  0.694
2014 Collier A, Blackman A, Foster G, Zammit G, Rosenberg R, Wadden T, Aronne L, Claudius B, Jensen T, Mignot E. S28 Liraglutide 3.0 Mg Reduces Severity Of Obstructive Sleep Apnoea And Body Weight In Obese Individuals With Moderate Or Severe Disease: Scale Sleep Apnoea Trial Thorax. 69: A16-A17. DOI: 10.1136/THORAXJNL-2014-206260.34  0.64
2014 Bahnson JL, Knowler WC, Bantle JP, Bertoni AG, Bray GA, Chen H, Cheskin L, Clark JM, Egan C, Evans M, Foreyt JP, Glasser SP, Greenway FL, Gregg EW, Hazuda HP, ... ... Wadden TA, et al. Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: A secondary analysis of the Look AHEAD randomised clinical trial The Lancet Diabetes and Endocrinology. 2: 801-809. DOI: 10.1016/S2213-8587(14)70156-1  0.301
2013 Sarwer DB, Spitzer JC, Wadden TA, Rosen RC, Mitchell JE, Lancaster K, Courcoulas A, Gourash W, Christian NJ. Sexual functioning and sex hormones in persons with extreme obesity and seeking surgical and nonsurgical weight loss. Surgery For Obesity and Related Diseases : Official Journal of the American Society For Bariatric Surgery. 9: 997-1007. PMID 24120985 DOI: 10.1016/J.Soard.2013.07.003  0.374
2013 Vetter ML, Wadden TA, Chittams J, Diewald LK, Panigrahi E, Volger S, Sarwer DB, Moore RH. Effect of lifestyle intervention on cardiometabolic risk factors: results of the POWER-UP trial. International Journal of Obesity (2005). 37: S19-24. PMID 23921777 DOI: 10.1038/Ijo.2013.92  0.361
2013 Volger S, Wadden TA, Sarwer DB, Moore RH, Chittams J, Diewald LK, Panigrahi E, Berkowitz RI, Schmitz K, Vetter ML. Changes in eating, physical activity and related behaviors in a primary care-based weight loss intervention. International Journal of Obesity (2005). 37: S12-8. PMID 23921776 DOI: 10.1038/Ijo.2013.91  0.37
2013 Wadden TA, Hollander P, Klein S, Niswender K, Woo V, Hale PM, Aronne L. Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE Maintenance randomized study. International Journal of Obesity (2005). 37: 1443-51. PMID 23812094 DOI: 10.1038/ijo.2013.120  0.441
2013 Wing RR, Bolin P, Brancati FL, Bray GA, Clark JM, Coday M, Crow RS, Curtis JM, Egan CM, Espeland MA, Evans M, Foreyt JP, Ghazarian S, Gregg EW, ... ... Wadden TA, et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. The New England Journal of Medicine. 369: 145-54. PMID 23796131 DOI: 10.1056/Nejmoa1212914  0.346
2013 Wing RR, Bond DS, Gendrano IN, Wadden T, Bahnson J, Lewis CE, Brancati F, Schneider S, Kitabchi AE, Van Dorsten B, Rosen RC. Effect of intensive lifestyle intervention on sexual dysfunction in women with type 2 diabetes: results from an ancillary Look AHEAD study. Diabetes Care. 36: 2937-44. PMID 23757437 DOI: 10.2337/Dc13-0315  0.323
2013 Abrams P, Levitt Katz LE, Moore RH, Xanthopoulos MS, Bishop-Gilyard CT, Wadden TA, Berkowitz RI. Threshold for improvement in insulin sensitivity with adolescent weight loss. The Journal of Pediatrics. 163: 785-90. PMID 23706362 DOI: 10.1016/j.jpeds.2013.04.003  0.359
2013 Kuna ST, Reboussin DM, Borradaile KE, Sanders MH, Millman RP, Zammit G, Newman AB, Wadden TA, Jakicic JM, Wing RR, Pi-Sunyer FX, Foster GD. Long-term effect of weight loss on obstructive sleep apnea severity in obese patients with type 2 diabetes. Sleep. 36: 641-649A. PMID 23633746 DOI: 10.5665/Sleep.2618  0.66
2013 Foster GD, Wadden TA, Lagrotte CA, Vander Veur SS, Hesson LA, Homko CJ, Maschak-Carey BJ, Barbor NR, Bailer B, Diewald L, Komaroff E, Herring SJ, Vetter ML. A randomized comparison of a commercially available portion-controlled weight-loss intervention with a diabetes self-management education program. Nutrition & Diabetes. 3: e63. PMID 23507967 DOI: 10.1038/Nutd.2013.3  0.655
2013 Unick JL, Beavers D, Bond DS, Clark JM, Jakicic JM, Kitabchi AE, Knowler WC, Wadden TA, Wagenknecht LE, Wing RR. The long-term effectiveness of a lifestyle intervention in severely obese individuals. The American Journal of Medicine. 126: 236-42, 242.e1-2. PMID 23410564 DOI: 10.1016/J.Amjmed.2012.10.010  0.4
2013 Carvajal R, Wadden TA, Tsai AG, Peck K, Moran CH. Managing obesity in primary care practice: A narrative review Annals of the New York Academy of Sciences. 1281: 191-206. PMID 23323827 DOI: 10.1111/nyas.12004  0.354
2013 Faulconbridge LF, Wadden TA, Thomas JG, Jones-Corneille LR, Sarwer DB, Fabricatore AN. Changes in depression and quality of life in obese individuals with binge eating disorder: bariatric surgery versus lifestyle modification. Surgery For Obesity and Related Diseases : Official Journal of the American Society For Bariatric Surgery. 9: 790-6. PMID 23260806 DOI: 10.1016/J.Soard.2012.10.010  0.36
2013 Tsai AG, Wadden TA. Obesity Annals of Internal Medicine. 159. DOI: 10.7326/0003-4819-159-5-201309030-01003  0.323
2013 Chirinos JA, Gurubhagavatula I, Pack A, Teff K, Wadden T, Rader D, Foster G, Hanlon A, Maislin G, Chittams J, Broderick P, Saif H, Townsend R. EFFECT OF CONTINUOUS-POSITIVE AIRWAY PRESSURE, WEIGHT LOSS OR BOTH ON LARGE ARTERY STIFFNESS IN SUBJECTS WITH OBSTRUCTS SLEEP APNEA Journal of the American College of Cardiology. 61: E1448. DOI: 10.1016/S0735-1097(13)61448-5  0.655
2013 Chirinos JA, Gurubhagavatula I, Townsend R, Teff K, Wadden T, Rader D, Foster G, Hanlon AL, Maislin G, Chittams J, Broderick P, Ahmad Z, Pack A. EFFECT OF CONTINUOUS-POSITIVE AIRWAY PRESSURE, WEIGHT LOSS OR BOTH ON PERIPHERAL AND CENTRAL BLOOD PRESSURE IN OBESE SUBJECTS WITH OBSTRUCTS SLEEP APNEA Journal of the American College of Cardiology. 61: E1384. DOI: 10.1016/S0735-1097(13)61384-4  0.681
2012 St-Onge MP, Zammit G, Reboussin DM, Kuna ST, Sanders MH, Millman R, Newman AB, Wadden TA, Wing RR, Pi-Sunyer FX, Foster GD. Associations of sleep disturbance and duration with metabolic risk factors in obese persons with type 2 diabetes: data from the Sleep AHEAD Study. Nature and Science of Sleep. 4: 143-50. PMID 23620687 DOI: 10.2147/Nss.S35797  0.584
2012 Vetter ML, Ritter S, Wadden TA, Sarwer DB. Comparison of Bariatric Surgical Procedures for Diabetes Remission: Efficacy and Mechanisms. Diabetes Spectrum : a Publication of the American Diabetes Association. 25: 200-210. PMID 23264721 DOI: 10.2337/diaspect.25.4.200  0.315
2012 Rice TB, Foster GD, Sanders MH, Unruh M, Reboussin D, Kuna ST, Millman R, Zammit G, Wing RR, Wadden TA, Kelley D, Pi-Sunyer X, Newman AB. The relationship between obstructive sleep apnea and self-reported stroke or coronary heart disease in overweight and obese adults with type 2 diabetes mellitus. Sleep. 35: 1293-8. PMID 22942508 DOI: 10.5665/Sleep.2090  0.604
2012 Demark-Wahnefried W, Platz EA, Ligibel JA, Blair CK, Courneya KS, Meyerhardt JA, Ganz PA, Rock CL, Schmitz KH, Wadden T, Philip EJ, Wolfe B, Gapstur SM, Ballard-Barbash R, McTiernan A, et al. The role of obesity in cancer survival and recurrence. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 1244-59. PMID 22695735 DOI: 10.1158/1055-9965.Epi-12-0485  0.372
2012 Glasgow RE, Gaglio B, Bennett G, Jerome GJ, Yeh HC, Sarwer DB, Appel L, Colditz G, Wadden TA, Wells B. Applying the PRECIS criteria to describe three effectiveness trials of weight loss in obese patients with comorbid conditions. Health Services Research. 47: 1051-67. PMID 22092292 DOI: 10.1111/J.1475-6773.2011.01347.X  0.421
2012 Kumanyika SK, Fassbender JE, Sarwer DB, Phipps E, Allison KC, Localio R, Morales KH, Wesby L, Harralson T, Kessler R, Tan-Torres S, Han X, Tsai AG, Wadden TA. One-year results of the Think Health! study of weight management in primary care practices. Obesity (Silver Spring, Md.). 20: 1249-57. PMID 22051940 DOI: 10.1038/oby.2011.329  0.384
2012 Faulconbridge LF, Wadden TA, Rubin RR, Wing RR, Walkup MP, Fabricatore AN, Coday M, Van Dorsten B, Mount DL, Ewing LJ. One-year changes in symptoms of depression and weight in overweight/obese individuals with type 2 diabetes in the Look AHEAD study. Obesity (Silver Spring, Md.). 20: 783-93. PMID 22016099 DOI: 10.1038/Oby.2011.315  0.319
2012 Volger S, Vetter ML, Dougherty M, Panigrahi E, Egner R, Webb V, Thomas JG, Sarwer DB, Wadden TA. Patients' preferred terms for describing their excess weight: discussing obesity in clinical practice. Obesity (Silver Spring, Md.). 20: 147-50. PMID 21760637 DOI: 10.1038/oby.2011.217  0.446
2011 Wadden TA, Wilson GT, Stunkard AJ, Berkowitz RI. Preface. Obesity and associated eating disorders: a guide for mental health professionals. The Psychiatric Clinics of North America. 34: xiii-xvi. PMID 22098813 DOI: 10.1016/j.psc.2011.09.001  0.345
2011 Butryn ML, Webb V, Wadden TA. Behavioral treatment of obesity. The Psychiatric Clinics of North America. 34: 841-59. PMID 22098808 DOI: 10.1016/J.Psc.2011.08.006  0.361
2011 Wadden TA, Volger S, Sarwer DB, Vetter ML, Tsai AG, Berkowitz RI, Kumanyika S, Schmitz KH, Diewald LK, Barg R, Chittams J, Moore RH. A two-year randomized trial of obesity treatment in primary care practice. The New England Journal of Medicine. 365: 1969-79. PMID 22082239 DOI: 10.1056/Nejmoa1109220  0.364
2011 Halpern CH, Torres N, Hurtig HI, Wolf JA, Stephen J, Oh MY, Williams NN, Dichter MA, Jaggi JL, Caplan AL, Kampman KM, Wadden TA, Whiting DM, Baltuch GH. Expanding applications of deep brain stimulation: a potential therapeutic role in obesity and addiction management. Acta Neurochirurgica. 153: 2293-306. PMID 21976235 DOI: 10.1007/s00701-011-1166-3  0.301
2011 Unick JL, Beavers D, Jakicic JM, Kitabchi AE, Knowler WC, Wadden TA, Wing RR. Effectiveness of lifestyle interventions for individuals with severe obesity and type 2 diabetes: results from the Look AHEAD trial. Diabetes Care. 34: 2152-7. PMID 21836103 DOI: 10.2337/Dc11-0874  0.374
2011 Wadden TA, Neiberg RH, Wing RR, Clark JM, Delahanty LM, Hill JO, Krakoff J, Otto A, Ryan DH, Vitolins MZ. Four-year weight losses in the Look AHEAD study: factors associated with long-term success. Obesity (Silver Spring, Md.). 19: 1987-98. PMID 21779086 DOI: 10.1038/oby.2011.230  0.388
2011 Faulconbridge LF, Wadden TA, Berkowitz RI, Pulcini ME, Treadwell T. Treatment of Comorbid Obesity and Major Depressive Disorder: A Prospective Pilot Study for their Combined Treatment. Journal of Obesity. 2011: 870385. PMID 21773011 DOI: 10.1155/2011/870385  0.329
2011 Wing RR, Lang W, Wadden TA, Safford M, Knowler WC, Bertoni AG, Hill JO, Brancati FL, Peters A, Wagenknecht L. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care. 34: 1481-6. PMID 21593294 DOI: 10.2337/Dc10-2415  0.385
2011 Fabricatore AN, Wadden TA, Higginbotham AJ, Faulconbridge LF, Nguyen AM, Heymsfield SB, Faith MS. Intentional weight loss and changes in symptoms of depression: a systematic review and meta-analysis. International Journal of Obesity (2005). 35: 1363-76. PMID 21343903 DOI: 10.1038/Ijo.2011.2  0.367
2011 Wadden TA, Faulconbridge LF, Jones-Corneille LR, Sarwer DB, Fabricatore AN, Thomas JG, Wilson GT, Alexander MG, Pulcini ME, Webb VL, Williams NN. Binge eating disorder and the outcome of bariatric surgery at one year: a prospective, observational study. Obesity (Silver Spring, Md.). 19: 1220-8. PMID 21253005 DOI: 10.1038/Oby.2010.336  0.367
2011 Fabricatore AN, Wadden TA, Ebbeling CB, Thomas JG, Stallings VA, Schwartz S, Ludwig DS. Targeting dietary fat or glycemic load in the treatment of obesity and type 2 diabetes: A randomized controlled trial Diabetes Research and Clinical Practice. 92: 37-45. PMID 21208675 DOI: 10.1016/J.Diabres.2010.12.016  0.311
2011 Bishop-Gilyard CT, Berkowitz RI, Wadden TA, Gehrman CA, Cronquist JL, Moore RH. Weight reduction in obese adolescents with and without binge eating. Obesity (Silver Spring, Md.). 19: 982-7. PMID 20948512 DOI: 10.1038/oby.2010.249  0.31
2011 Wadden TA, Foreyt JP, Foster GD, Hill JO, Klein S, O'Neil PM, Perri MG, Pi-Sunyer FX, Rock CL, Erickson JS, Maier HN, Kim DD, Dunayevich E. Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial. Obesity (Silver Spring, Md.). 19: 110-20. PMID 20559296 DOI: 10.1038/Oby.2010.147  0.626
2010 Vetter ML, Wade A, Womble LG, Dalton-Bakes C, Wadden TA, Iqbal N. Effect of a low-carbohydrate diet versus a low-fat, calorie-restricted diet on adipokine levels in obese, diabetic participants. Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy. 3: 357-61. PMID 21437105 DOI: 10.2147/DMSOTT.S13966  0.385
2010 Vetter ML, Faulconbridge LF, Webb VL, Wadden TA. Behavioral and pharmacologic therapies for obesity. Nature Reviews. Endocrinology. 6: 578-88. PMID 20680034 DOI: 10.1038/Nrendo.2010.121  0.448
2010 Foster GD, Wyatt HR, Hill JO, Makris AP, Rosenbaum DL, Brill C, Stein RI, Mohammed BS, Miller B, Rader DJ, Zemel B, Wadden TA, Tenhave T, Newcomb CW, Klein S. Weight and metabolic outcomes after 2 years on a low-carbohydrate versus low-fat diet: a randomized trial. Annals of Internal Medicine. 153: 147-57. PMID 20679559 DOI: 10.7326/0003-4819-153-3-201008030-00005  0.641
2010 Wadden TA, Fujioka K, Toubro S, Gantz I, Erondu NE, Chen M, Suryawanshi S, Carofano W, Johnson-Levonas AO, Shapiro DR, Kaufman KD, Heymsfield SB, Amatruda JM. A randomized trial of lifestyle modification and taranabant for maintaining weight loss achieved with a low-calorie diet. Obesity (Silver Spring, Md.). 18: 2301-10. PMID 20379151 DOI: 10.1038/oby.2010.67  0.433
2010 Vetter ML, Iqbal N, Dalton-Bakes C, Volger S, Wadden TA. Long-term effects of low-carbohydrate versus low-fat diets in obese persons. Annals of Internal Medicine. 152: 334-5. PMID 20194246 DOI: 10.7326/0003-4819-152-5-201003020-00020  0.302
2010 Tsai AG, Wadden TA, Rogers MA, Day SC, Moore RH, Islam BJ. A primary care intervention for weight loss: results of a randomized controlled pilot study. Obesity (Silver Spring, Md.). 18: 1614-8. PMID 20019680 DOI: 10.1038/oby.2009.457  0.436
2010 Iqbal N, Vetter ML, Moore RH, Chittams JL, Dalton-Bakes CV, Dowd M, Williams-Smith C, Cardillo S, Wadden TA. Effects of a low-intensity intervention that prescribed a low-carbohydrate vs. a low-fat diet in obese, diabetic participants. Obesity (Silver Spring, Md.). 18: 1733-8. PMID 20019677 DOI: 10.1038/oby.2009.460  0.352
2010 Wing RR, Rosen RC, Fava JL, Bahnson J, Brancati F, Gendrano INC, Kitabchi A, Schneider SH, Wadden TA. Effects of weight loss intervention on erectile function in older men with type 2 diabetes in the Look AHEAD Trial Journal of Sexual Medicine. 7: 156-165. PMID 19694925 DOI: 10.1111/J.1743-6109.2009.01458.X  0.349
2010 Foster GD, Wyatt HR, Hill JO, Makris AP, Rosenbaum DL, Brill C, Stein RI, Mohammed S, Miller B, Rader DJ, Zemel B, Wadden TA, Tenhave T, Newcomb CW, Klein S. Weight and Metabolic Outcomes After 2 Years on a Low-Carbohydrate Versus Low-Fat Diet Obstetrical & Gynecological Survey. 65: 769-770. DOI: 10.1097/Ogx.0B013E31821342Ba  0.635
2010 Faulconbridge L, Wadden T, Pulcini M, Dobson T. Improvements in weight, mood and cardiovascular disease risk factors in obese individuals with clinical depression Appetite. 54: 645. DOI: 10.1016/J.Appet.2010.04.066  0.313
2009 Kumanyika SK, Wadden TA, Shults J, Fassbender JE, Brown SD, Bowman MA, Brake V, West W, Frazier J, Whitt-Glover MC, Kallan MJ, Desnouee E, Wu X. Trial of family and friend support for weight loss in African American adults. Archives of Internal Medicine. 169: 1795-804. PMID 19858438 DOI: 10.1001/Archinternmed.2009.337  0.336
2009 Foster GD, Borradaile KE, Sanders MH, Millman R, Zammit G, Newman AB, Wadden TA, Kelley D, Wing RR, Pi-Sunyer FX, Reboussin D, Kuna ST. A randomized study on the effect of weight loss on obstructive sleep apnea among obese patients with type 2 diabetes: the Sleep AHEAD study. Archives of Internal Medicine. 169: 1619-26. PMID 19786682 DOI: 10.1001/Archinternmed.2009.266  0.723
2009 Wadden TA. Exploring synergies in the treatment of obesity. Postgraduate Medicine. 109: 29-33. PMID 19667565 DOI: 10.3810/pgm.06.2001.suppl14.76  0.432
2009 Fabricatore AN, Wadden TA, Moore RH, Butryn ML, Heymsfield SB, Nguyen AM. Predictors of attrition and weight loss success: Results from a randomized controlled trial. Behaviour Research and Therapy. 47: 685-91. PMID 19497559 DOI: 10.1016/J.Brat.2009.05.004  0.414
2009 Aronne LJ, Wadden T, Isoldi KK, Woodworth KA. When prevention fails: obesity treatment strategies. The American Journal of Medicine. 122: S24-32. PMID 19410674 DOI: 10.1016/J.Amjmed.2009.01.005  0.567
2009 Fabricatore AN, Wadden TA, Moore RH, Butryn ML, Gravallese EA, Erondu NE, Heymsfield SB, Nguyen AM. Attrition from randomized controlled trials of pharmacological weight loss agents: a systematic review and analysis. Obesity Reviews : An Official Journal of the International Association For the Study of Obesity. 10: 333-41. PMID 19389060 DOI: 10.1111/j.1467-789X.2009.00567.x  0.311
2009 Foster GD, Sanders MH, Millman R, Zammit G, Borradaile KE, Newman AB, Wadden TA, Kelley D, Wing RR, Sunyer FX, Darcey V, Kuna ST. Obstructive sleep apnea among obese patients with type 2 diabetes. Diabetes Care. 32: 1017-9. PMID 19279303 DOI: 10.2337/Dc08-1776  0.617
2009 Tsai AG, Wadden TA, Pillitteri JL, Sembower MA, Gerlach KK, Kyle TK, Burroughs VJ. Disparities by ethnicity and socioeconomic status in the use of weight loss treatments. Journal of the National Medical Association. 101: 62-70. PMID 19245074 DOI: 10.1016/S0027-9684(15)30813-0  0.355
2009 Faulconbridge LF, Wadden TA, Berkowitz RI, Sarwer DB, Womble LG, Hesson LA, Stunkard AJ, Fabricatore AN. Changes in symptoms of depression with weight loss: results of a randomized trial. Obesity (Silver Spring, Md.). 17: 1009-16. PMID 19197266 DOI: 10.1038/Oby.2008.647  0.335
2009 Rosen RC, Wing RR, Schneider S, Wadden TA, Foster GD, West DS, Kitabchi AE, Brancati FL, Maschak-Carey BJ, Bahnson JL, Lewis CE, Gendrano Iii IN. Erectile dysfunction in type 2 diabetic men: relationship to exercise fitness and cardiovascular risk factors in the Look AHEAD trial. The Journal of Sexual Medicine. 6: 1414-22. PMID 19192106 DOI: 10.1111/J.1743-6109.2008.01209.X  0.51
2009 Wadden TA, West DS, Neiberg RH, Wing RR, Ryan DH, Johnson KC, Foreyt JP, Hill JO, Trence DL, Vitolins MZ. One-year weight losses in the Look AHEAD study: factors associated with success. Obesity (Silver Spring, Md.). 17: 713-22. PMID 19180071 DOI: 10.1038/oby.2008.637  0.364
2009 Faulconbridge L, Wadden T, Jones-Corneille L, Sarwer D, Pulcini M, Bergelson L. Improvements in weight, mood and CVD risk factors in depressed, obese patients treated by lifestyle modification Appetite. 52: 831. DOI: 10.1016/J.Appet.2009.04.070  0.342
2008 Gorin AA, Niemeier HM, Hogan P, Coday M, Davis C, DiLillo VG, Gluck ME, Wadden TA, West DS, Williamson D, Yanovski SZ. Binge eating and weight loss outcomes in overweight and obese individuals with type 2 diabetes: results from the Look AHEAD trial. Archives of General Psychiatry. 65: 1447-55. PMID 19047532 DOI: 10.1001/Archpsyc.65.12.1447  0.421
2008 Sarwer DB, Fabricatore AN, Eisenberg MH, Sywulak LA, Wadden TA. Self-reported stigmatization among candidates for bariatric surgery. Obesity (Silver Spring, Md.). 16: S75-9. PMID 18978767 DOI: 10.1038/oby.2008.450  0.391
2008 Fabricatore AN, Wadden TA, Rohay JM, Pillitteri JL, Shiffman S, Harkins AM, Burton SL. Weight loss expectations and goals in a population sample of overweight and obese US adults. Obesity (Silver Spring, Md.). 16: 2445-50. PMID 18719676 DOI: 10.1038/Oby.2008.383  0.468
2008 Sarwer DB, Wadden TA, Moore RH, Baker AW, Gibbons LM, Raper SE, Williams NN. Preoperative eating behavior, postoperative dietary adherence, and weight loss after gastric bypass surgery. Surgery For Obesity and Related Diseases : Official Journal of the American Society For Bariatric Surgery. 4: 640-6. PMID 18586571 DOI: 10.1016/j.soard.2008.04.013  0.322
2008 Pillitteri JL, Shiffman S, Rohay JM, Harkins AM, Burton SL, Wadden TA. Use of dietary supplements for weight loss in the United States: results of a national survey. Obesity (Silver Spring, Md.). 16: 790-6. PMID 18239570 DOI: 10.1038/Oby.2007.136  0.382
2008 Stettler N, Berkowtiz RI, Cronquist JL, Shults J, Wadden TA, Zemel BS, Leonard MB. Observational study of bone accretion during successful weight loss in obese adolescents. Obesity (Silver Spring, Md.). 16: 96-101. PMID 18223619 DOI: 10.1038/Oby.2007.17  0.308
2007 Wadden TA, Sarwer DB, Fabricatore AN, Jones L, Stack R, Williams NS. Psychosocial and behavioral status of patients undergoing bariatric surgery: what to expect before and after surgery. The Medical Clinics of North America. 91: 451-69, xi-xii. PMID 17509389 DOI: 10.1016/j.mcna.2007.01.003  0.303
2007 Wadden TA, Butryn ML, Wilson C. Lifestyle modification for the management of obesity. Gastroenterology. 132: 2226-38. PMID 17498514 DOI: 10.1053/J.Gastro.2007.03.051  0.439
2007 Fabricatore AN, Wadden TA, Womble LG, Sarwer DB, Berkowitz RI, Foster GD, Brock JR. The role of patients' expectations and goals in the behavioral and pharmacological treatment of obesity. International Journal of Obesity (2005). 31: 1739-45. PMID 17471295 DOI: 10.1038/Sj.Ijo.0803649  0.663
2007 Erondu N, Wadden T, Gantz I, Musser B, Nguyen AM, Bays H, Bray G, O'Neil PM, Basdevant A, Kaufman KD, Heymsfield SB, Amatruda JM. Effect of NPY5R antagonist MK-0557 on weight regain after very-low-calorie diet-induced weight loss. Obesity (Silver Spring, Md.). 15: 895-905. PMID 17426325 DOI: 10.1038/Oby.2007.620  0.475
2007 Crerand CE, Wadden TA, Foster GD, Sarwer DB, Paster LM, Berkowitz RI. Changes in obesity-related attitudes in women seeking weight reduction. Obesity (Silver Spring, Md.). 15: 740-7. PMID 17372325 DOI: 10.1038/Oby.2007.590  0.666
2007 Jones LR, Wilson CI, Wadden TA. Lifestyle modification in the treatment of obesity: an educational challenge and opportunity. Clinical Pharmacology and Therapeutics. 81: 776-9. PMID 17361122 DOI: 10.1038/sj.clpt.6100155  0.445
2007 Phelan S, Wadden TA, Berkowitz RI, Sarwer DB, Womble LG, Cato RK, Rothman R. Impact of weight loss on the metabolic syndrome International Journal of Obesity. 31: 1442-1448. PMID 17356528 DOI: 10.1038/sj.ijo.0803606  0.323
2006 Fabricatore AN, Wadden TA. Obesity. Annual Review of Clinical Psychology. 2: 357-77. PMID 17716074 DOI: 10.1146/annurev.clinpsy.2.022305.095249  0.323
2006 Tsai AG, Asch DA, Wadden TA. Insurance coverage for obesity treatment. Journal of the American Dietetic Association. 106: 1651-5. PMID 17000198 DOI: 10.1016/J.JADA.2006.07.012  0.384
2006 Tsai AG, Wadden TA. The evolution of very-low-calorie diets: an update and meta-analysis. Obesity (Silver Spring, Md.). 14: 1283-93. PMID 16988070 DOI: 10.1038/OBY.2006.146  0.334
2006 Jones LR, Wadden TA. State of the science: behavioural treatment of obesity. Asia Pacific Journal of Clinical Nutrition. 15: 30-9. PMID 16928659  0.421
2006 Wadden TA, Foster GD. Weight and Lifestyle Inventory (WALI). Surgery For Obesity and Related Diseases : Official Journal of the American Society For Bariatric Surgery. 2: 180-99. PMID 16925345 DOI: 10.1016/J.Soard.2006.03.017  0.671
2006 Crerand CE, Wadden TA, Sarwer DB, Fabricatore AN, Kuehnel RH, Gibbons LM, Brock JR, Williams NN. A comparison of weight histories in women with class III vs. class I-II obesity. Surgery For Obesity and Related Diseases : Official Journal of the American Society For Bariatric Surgery. 2: 165-70. PMID 16925343 DOI: 10.1016/j.soard.2006.03.012  0.376
2006 Wadden TA, Butryn ML, Sarwer DB, Fabricatore AN, Crerand CE, Lipschutz PE, Faulconbridge L, Raper S, Williams NN. Comparison of psychosocial status in treatment-seeking women with class III vs. class I-II obesity. Surgery For Obesity and Related Diseases : Official Journal of the American Society For Bariatric Surgery. 2: 138-45. PMID 16925339 DOI: 10.1016/J.Soard.2006.03.016  0.366
2006 Wadden TA, Foster GD. Weight and Lifestyle Inventory (WALI) Obesity (Silver Spring, Md.). 14. PMID 16648601 DOI: 10.1038/Oby.2006.289  0.688
2006 Wadden TA, Butryn ML, Sarwer DB, Fabricatore AN, Crerand CE, Lipschutz PE, Faulconbridge L, Raper SE, Williams NN. Comparison of psychosocial status in treatment-seeking women with class III vs. class I-II obesity. Obesity (Silver Spring, Md.). 14: 90S-98S. PMID 16648600 DOI: 10.1038/Oby.2006.288  0.366
2006 Crerand CE, Wadden TA, Sarwer DB, Fabricatore AN, Kuehnel RH, Gibbons LM, Brock JR, Williams NN. A comparison of weight histories in women with class III vs. class I-II obesity. Obesity (Silver Spring, Md.). 14: 63S-69S. PMID 16648596 DOI: 10.1038/oby.2006.284  0.376
2005 Buchwald H, Owen H, Wangensteen SD, Billington CJ, Detre KM, Garcia V, Jensen MD, Kelley DE, Klein S, Danforth WH, O'Leary JP, Sheldon GF, Wadden T, Wittgrove A, Wolfe BM. Consensus Conference Statement. Bariatric surgery for morbid obesity: Health implications for patients, health professionals, and third-party payers Surgery For Obesity and Related Diseases. 1: 371-381. PMID 16925250 DOI: 10.1016/J.Soard.2005.04.002  0.333
2005 Wadden TA, Berkowitz RI, Womble LG, Sarwer DB, Phelan S, Cato RK, Hesson LA, Osei SY, Kaplan R, Stunkard AJ. Randomized trial of lifestyle modification and pharmacotherapy for obesity. The New England Journal of Medicine. 353: 2111-20. PMID 16291981 DOI: 10.1056/NEJMOA050156  0.363
2005 Sarwer DB, Wadden TA, Fabricatore AN. Psychosocial and behavioral aspects of bariatric surgery. Obesity Research. 13: 639-48. PMID 15897471 DOI: 10.1038/oby.2005.71  0.302
2005 Wadden TA, Crerand CE, Brock J. Behavioral treatment of obesity. The Psychiatric Clinics of North America. 28: 151-70, ix. PMID 15733617 DOI: 10.1016/j.psc.2004.09.008  0.308
2005 Tsai AG, Wadden TA. Systematic review: an evaluation of major commercial weight loss programs in the United States. Annals of Internal Medicine. 142: 56-66. PMID 15630109 DOI: 10.7326/0003-4819-142-1-200501040-00012  0.317
2005 Wadden TA. Adverse psychosocial consequences of extreme obesity and the effects of surgically induced weight loss Surgery For Obesity and Related Diseases. 1: 56-58. DOI: 10.1016/J.SOARD.2004.12.019  0.45
2004 Wadden TA, Butryn ML, Byrne KJ. Efficacy of lifestyle modification for long-term weight control. Obesity Research. 12: 151S-62S. PMID 15687411 DOI: 10.1038/Oby.2004.282  0.374
2004 Fabricatore AN, Wadden TA. Psychological aspects of obesity. Clinics in Dermatology. 22: 332-7. PMID 15475235 DOI: 10.1016/j.clindermatol.2004.01.006  0.376
2004 Foster GD, Phelan S, Wadden TA, Gill D, Ermold J, Didie E. Promoting more modest weight losses: a pilot study. Obesity Research. 12: 1271-7. PMID 15340110 DOI: 10.1038/Oby.2004.161  0.676
2004 Wadden TA, Foster GD, Sarwer DB, Anderson DA, Gladis M, Sanderson RS, Letchak RV, Berkowitz RI, Phelan S. Dieting and the development of eating disorders in obese women: results of a randomized controlled trial. The American Journal of Clinical Nutrition. 80: 560-8. PMID 15321793 DOI: 10.1093/Ajcn/80.3.560  0.623
2004 Wang SS, Brownell KD, Wadden TA. The influence of the stigma of obesity on overweight individuals International Journal of Obesity. 28: 1333-1337. PMID 15278101 DOI: 10.1038/sj.ijo.0802730  0.366
2004 Womble LG, Wadden TA, McGuckin BG, Sargent SL, Rothman RA, Krauthamer-Ewing ES. A randomized controlled trial of a commercial internet weight loss program. Obesity Research. 12: 1011-8. PMID 15229342 DOI: 10.1038/oby.2004.124  0.385
2004 Wadden TA, Didie E. What's in a name? Patients' preferred terms for describing obesity. Obesity Research. 11: 1140-6. PMID 12972685 DOI: 10.1038/Oby.2003.155  0.382
2003 Wadden TA, Butryn ML. Behavioral treatment of obesity. Endocrinology and Metabolism Clinics of North America. 32: 981-1003, x. PMID 14711071 DOI: 10.1016/S0889-8529(03)00072-0  0.436
2003 Wadden TA, Womble LG, Sarwer DB, Berkowitz RI, Clark VL, Foster GD. Great expectations: "I'm losing 25% of my weight no matter what you say". Journal of Consulting and Clinical Psychology. 71: 1084-9. PMID 14622084 DOI: 10.1037/0022-006X.71.6.1084  0.714
2003 Foster GD, Wadden TA, Makris AP, Davidson D, Sanderson RS, Allison DB, Kessler A. Primary care physicians' attitudes about obesity and its treatment. Obesity Research. 11: 1168-77. PMID 14569041 DOI: 10.1038/Oby.2003.161  0.618
2003 Berkowitz RI, Wadden TA, Tershakovec AM, Cronquist JL. Behavior therapy and sibutramine for the treatment of adolescent obesity: a randomized controlled trial. Jama. 289: 1805-12. PMID 12684359 DOI: 10.1001/JAMA.289.14.1805  0.357
2002 Jain AK, Kaplan RA, Gadde KM, Wadden TA, Allison DB, Brewer ER, Leadbetter RA, Richard N, Haight B, Jamerson BD, Buaron KS, Metz A. Bupropion SR vs. placebo for weight loss in obese patients with depressive symptoms. Obesity Research. 10: 1049-56. PMID 12376586 DOI: 10.1038/Oby.2002.142  0.355
2002 Matz PE, Foster GD, Faith MS, Wadden TA. Correlates of body image dissatisfaction among overweight women seeking weight loss Journal of Consulting and Clinical Psychology. 70: 1040-1044. PMID 12182267 DOI: 10.1037/0022-006X.70.4.1040  0.648
2002 Welch KC, Foster GD, Ritter CT, Wadden TA, Arens R, Maislin G, Schwab RJ. A novel volumetric magnetic resonance imaging paradigm to study upper airway anatomy. Sleep. 25: 532-42. PMID 12150320 DOI: 10.1093/Sleep/25.5.530  0.477
2002 Wadden TA, Brownell KD, Foster GD. Obesity: responding to the global epidemic. Journal of Consulting and Clinical Psychology. 70: 510-25. PMID 12090366 DOI: 10.1037//0022-006X.70.3.510  0.627
2002 Miles JM, Leiter L, Hollander P, Wadden T, Anderson JW, Doyle M, Foreyt J, Aronne L, Klein S. Effect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin. Diabetes Care. 25: 1123-8. PMID 12087008 DOI: 10.2337/DIACARE.25.7.1123  0.308
2002 Phelan S, Wadden TA. Combining behavioral and pharmacological treatments for obesity. Obesity Research. 10: 560-74. PMID 12055334 DOI: 10.1038/OBY.2002.77  0.324
2002 Miles JM, Leiter L, Hollander P, Wadden T, Anderson JW, Doyle M, Foreyt J, Aronne L, Klein S. Erratum: Effect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin (Diabetes Care (2002) 25 (1123-1128)) Diabetes Care. 25. DOI: 10.2337/Diacare.25.9.1671  0.351
2001 Wadden TA, Sarwer DB, Womble LG, Foster GD, McGuckin BG, Schimmel A. Psychosocial aspects of obesity and obesity surgery. The Surgical Clinics of North America. 81: 1001-24. PMID 11589242 DOI: 10.1016/S0039-6109(05)70181-X  0.657
2001 Foster GD, Wadden TA, Phelan S, Sarwer DB, Sanderson RS. Obese patients' perceptions of treatment outcomes and the factors that influence them Archives of Internal Medicine. 161: 2133-2139. PMID 11570944 DOI: 10.1001/Archinte.161.17.2133  0.708
2001 Lowe MR, Foster GD, Kerzhnerman I, Swain RM, Wadden TA. Restrictive dieting vs. "undieting" effects on eating regulation in obese clinic attenders. Addictive Behaviors. 26: 253-66. PMID 11316380 DOI: 10.1016/S0306-4603(00)00106-4  0.656
2001 Wadden TA, Berkowitz RI, Sarwer DB, Prus-Wisniewski R, Steinberg C. Benefits of lifestyle modification in the pharmacologic treatment of obesity: a randomized trial. Archives of Internal Medicine. 161: 218-27. PMID 11176735 DOI: 10.1001/Archinte.161.2.218  0.424
2000 Wadden TA, Anderson DA, Foster GD, Bennett A, Steinberg C, Sarwer DB. Obese women's perceptions of their physicians' weight management attitudes and practices Archives of Family Medicine. 9: 854-860. PMID 11031392 DOI: 10.1001/Archfami.9.9.854  0.675
2000 Wadden TA, Berkowitz RI, Womble LG, Sarwer DB, Arnold ME, Steinberg CM. Effects of sibutramine plus orlistat in obese women following 1 year of treatment by sibutramine alone: A placebo-controlled trial Obesity Research. 8: 431-437. PMID 11011909 DOI: 10.1038/Oby.2000.53  0.426
2000 Yanovski SZ, Billington CJ, Epstein LH, Goodwin NJ, Hill JO, Pi-Sunyer FX, Rolls BJ, Stern JS, Wadden TA, Weinsier RL, Wilson GT, Wing RR, Van Hubbard S, Hoofnagle JH, Everhart J, et al. Dieting and the development of eating disorders in overweight and obese adults Archives of Internal Medicine. 160: 2581-2589. PMID 10999971 DOI: 10.1001/Archinte.160.17.2581  0.495
2000 Wadden TA, Sarwer DB, Berkowitz RI. Behavioural treatment of the overweight patient. Bailliere's Best Practice & Research. Clinical Endocrinology & Metabolism. 13: 93-107. PMID 10932678 DOI: 10.1053/BEEM.1999.0008  0.459
2000 Sarwer DB, Wadden TA. The treatment of obesity: what's new, what's recommended. Journal of Women's Health & Gender-Based Medicine. 8: 483-93. PMID 10839703 DOI: 10.1089/JWH.1.1999.8.483  0.514
1999 Wadden TA, Silvestry FE, Aber JL, Berkowitz RI, Foster GD, Sutton MG. Valvular heart disease in fenfluramine- phentermine-treated patients: a comparison with control patients. Obesity Research. 7: 309-10. PMID 10348504 DOI: 10.1002/j.1550-8528.1999.tb00412.x  0.489
1999 Wadden TA, Anderson DA, Foster GD. Two-year changes in lipids and lipoproteins associated with the maintenance of a 5 % to 10% reduction in initial weight: some findings and some questions Obesity Research. 7: 170-178. PMID 10102254 DOI: 10.1002/J.1550-8528.1999.Tb00699.X  0.629
1999 Andersen RE, Wadden TA, Bartlett SJ, Zemel B, Verde TJ, Franckowiak SC. Effects of lifestyle activity vs structured aerobic exercise in obese women: a randomized trial. Jama. 281: 335-40. PMID 9929086 DOI: 10.1001/JAMA.281.4.335  0.339
1999 Foster GD, Wadden TA, Swain RM, Anderson DA, Vogt RA. Changes in resting energy expenditure after weight loss in obese African American and white women. The American Journal of Clinical Nutrition. 69: 13-7. PMID 9925117 DOI: 10.1093/Ajcn/69.1.13  0.686
1999 Scanga CB, Verde TJ, Paolone AM, Andersen RE, Wadden TA. Effects of weight loss and exercise training on natural killer cell activity in obese women. Medicine and Science in Sports and Exercise. 30: 1666-71. PMID 9861597 DOI: 10.1097/00005768-199812000-00002  0.336
1998 Stunkard AJ, LaFleur WR, Wadden TA. Stigmatization of obesity in medieval times: Asia and Europe International Journal of Obesity. 22: 1141-1144. PMID 9877248 DOI: 10.1038/Sj.Ijo.0800753  0.423
1998 Sarwer DB, Wadden TA, Foster GD. Assessment of body image dissatisfaction in obese women: Specificity, severity, and clinical significance Journal of Consulting and Clinical Psychology. 66: 651-654. PMID 9735582 DOI: 10.1037//0022-006X.66.4.651  0.624
1998 Foster GD, Wadden TA, Swain RM, Stunkard AJ, Platte P, Vogt RA. The Eating Inventory in obese women: clinical correlates and relationship to weight loss. International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association For the Study of Obesity. 22: 778-85. PMID 9725638 DOI: 10.1038/Sj.Ijo.0800659  0.713
1998 Dandona P, Weinstock R, Thusu K, Abdel-Rahman E, Aljada A, Wadden T. Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss. The Journal of Clinical Endocrinology and Metabolism. 83: 2907-10. PMID 9709967 DOI: 10.1210/Jcem.83.8.5026  0.483
1998 Wadden TA, Berkowitz RI, Silvestry F, Vogt RA, St John Sutton MG, Stunkard AJ, Foster GD, Aber JL. The fen-phen finale: a study of weight loss and valvular heart disease. Obesity Research. 6: 278-84. PMID 9688104 DOI: 10.1002/J.1550-8528.1998.Tb00350.X  0.667
1998 Gladis MM, Wadden TA, Vogt R, Foster G, Kuehnel RH, Bartlett SJ. Behavioral treatment of obese binge eaters: do they need different care? Journal of Psychosomatic Research. 44: 375-84. PMID 9587881 DOI: 10.1016/S0022-3999(97)00262-6  0.71
1998 Wadden TA, Vogt RA, Foster GD, Anderson DA. Exercise and the maintenance of weight loss: 1-year follow-up of a controlled clinical trial Journal of Consulting and Clinical Psychology. 66: 429-433. PMID 9583346 DOI: 10.1037/0022-006X.66.2.429  0.637
1998 Wadden TA, Considine RV, Foster GD, Anderson DA, Sarwer DB, Caro JS. Short- and long-term changes in serum leptin in dieting obese women: Effects of caloric restriction and weight loss Journal of Clinical Endocrinology and Metabolism. 83: 214-218. PMID 9435444 DOI: 10.1210/Jcem.83.1.4494  0.695
1998 Sarwer DB, Wadden TA, Foster GD. Assessment of body image dissatisfaction in obese women: Specificity, severity, and clinical significance. Journal of Consulting and Clinical Psychology. 66: 651-654. DOI: 10.1037/0022-006X.66.4.651  0.309
1997 Gladis MM, Wadden TA, Foster GD, Vogt RA, Wingate BJ. A comparison of two approaches to the assessment of Binge Eating in obesity International Journal of Eating Disorders. 23: 17-26. PMID 9429915 DOI: 10.1002/(Sici)1098-108X(199801)23:1<17::Aid-Eat3>3.0.Co;2-4  0.663
1997 Wadden TA, Frey DL. A multicenter evaluation of a proprietary weight loss program for the treatment of marked obesity: a five-year follow-up. The International Journal of Eating Disorders. 22: 203-12. PMID 9261660 DOI: 10.1002/(SICI)1098-108X(199709)22:2<203::AID-EAT13>3.0.CO;2-1  0.459
1997 Wadden TA, Berkowitz RI, Vogt RA, Steen SN, Stunkard AJ, Foster GD. Lifestyle modification in the pharmacologic treatment of obesity: a pilot investigation of a potential primary care approach. Obesity Research. 5: 218-26. PMID 9192396 DOI: 10.1002/J.1550-8528.1997.Tb00296.X  0.689
1997 Foster GD, Wadden TA, Vogt RA. Body Image in Obese Women Before, During, and after Weight Loss Treatment Health Psychology. 16: 226-229. PMID 9152700 DOI: 10.1037//0278-6133.16.3.226  0.681
1997 Foster GD, Wadden TA, Vogt RA, Brewer G. What is a reasonable weight loss? Patients' expectations and evaluations of obesity treatment outcomes Journal of Consulting and Clinical Psychology. 65: 79-85. PMID 9103737 DOI: 10.1037//0022-006X.65.1.79  0.71
1997 Foster GD, Wadden TA, Vogt RA. Energy expenditure in obese african american and caucasian women Obesity Research. 5: 1-8. PMID 9061709 DOI: 10.1002/J.1550-8528.1997.Tb00276.X  0.667
1997 Foster GD, Wadden TA, Vogt RA. Body image in obese women before, during, and after weight loss treatment. Health Psychology. 16: 226-229. DOI: 10.1037/0278-6133.16.3.226  0.442
1997 Wadden TA, Vogt RA, Andersen RE, Bartlett SJ, Foster GD, Kuehnel RH, Wilk J, Weinstock R, Buckenmeyer P, Berkowitz RI, Steen SN. Exercise in the treatment of obesity: Effects of four interventions on body composition, resting energy expenditure, appetite, and mood. Journal of Consulting and Clinical Psychology. 65: 269-277. DOI: 10.1037/0022-006X.65.2.269  0.611
1996 Steen SN, Wadden TA, Foster GD, Andersen RE. Are obese adolescent boys ignoring an important health risk? International Journal of Eating Disorders. 20: 281-286. PMID 8912040 DOI: 10.1002/(Sici)1098-108X(199611)20:3<281::Aid-Eat7>3.0.Co;2-K  0.705
1996 Foster GD, Kendall PC, Wadden TA, Stunkard AJ, Vogt RA. Psychological effects of weight loss and regain: A prospective evaluation Journal of Consulting and Clinical Psychology. 64: 752-757. PMID 8803365 DOI: 10.1037//0022-006X.64.4.752  0.698
1996 Wadden TA, Bartlett SJ, Foster GD, Greenstein RA, Wingate BJ, Stunkard AJ, Letizia KA. Sertraline and relapse prevention training following treatment by very-low-calorie diet: a controlled clinical trial. Obesity Research. 3: 549-57. PMID 8653531 DOI: 10.1002/J.1550-8528.1995.Tb00189.X  0.678
1996 Wadden TA, Foster GD, Stunkard AJ, Conill AM. Effects of weight cycling on the resting energy expenditure and body composition of obese women International Journal of Eating Disorders. 19: 5-12. PMID 8640202 DOI: 10.1002/(Sici)1098-108X(199601)19:1<5::Aid-Eat2>3.0.Co;2-T  0.679
1996 Wadden TA, Steen SN, Wingate BJ, Foster GD. Psychosocial consequences of weight reduction: How much weight loss is enough? American Journal of Clinical Nutrition. 63. PMID 8615343 DOI: 10.1093/Ajcn/63.3.461  0.714
1996 Bartlett SJ, Wadden TA, Vogt RA. Psychosocial consequences of weight cycling. Journal of Consulting and Clinical Psychology. 64: 587-592. DOI: 10.1037/0022-006X.64.3.587  0.356
1995 Andersen RE, Wadden TA, Bartlett SJ, Vogt RA, Weinstock RS. Relation of weight loss to changes in serum lipids and lipoproteins in obese women. The American Journal of Clinical Nutrition. 62: 350-7. PMID 7625342 DOI: 10.1093/ajcn/62.2.350  0.409
1995 FOSTER GD, WADDEN TA, KENDRICK ZV, LETIZIA KA, LANDER DP, CONILL AM. The energy cost of walking before and after significant weight loss Medicine & Science in Sports & Exercise. 27: 888???894. DOI: 10.1249/00005768-199506000-00014  0.672
1995 Steen SN, Andersen RE, Wadden TA, Miles DS, Bartlett SJ, Foster GD. BODY COMPOSITION IN OBESE WOMEN PREDICTED FROM MULTI FREQUENCY BIOELECTRIC IMPEDANCE WITH DISTAL AND PROXIMAL ELECTRODE PLACEMENT Medicine & Science in Sports & Exercise. 27: S184. DOI: 10.1249/00005768-199505001-01037  0.59
1995 Andersen RE, Wadden TA, Herzog RJ, Dick M, Erhlich I, Bartlett SJ, Foster GD, Vogt R, Steen SN. RESISTANCE TRAINING DOES NOT SPARE THE LOSS OF FEMORAL BONE DENSITY IN OBESE DIETING WOMEN Medicine & Science in Sports & Exercise. 27: S139. DOI: 10.1249/00005768-199505001-00782  0.596
1994 Wadden TA, Foster GD, Letizia KA. One-Year Behavioral Treatment of Obesity: Comparison of Moderate and Severe Caloric Restriction and the Effects of Weight Maintenance Therapy Journal of Consulting and Clinical Psychology. 62: 165-171. PMID 8034818 DOI: 10.1037/0022-006X.62.1.165  0.693
1994 Kuehnel RH, Wadden TA. Binge eating disorder, weight cycling, and psychopathology. The International Journal of Eating Disorders. 15: 321-9. PMID 8032347 DOI: 10.1002/EAT.2260150403  0.373
1994 Stallone DD, Stunkard AJ, Zweiman B, Wadden TA, Foster GD. Decline in delayed-type hypersensitivity response in obese women following weight reduction Clinical and Diagnostic Laboratory Immunology. 1: 202-205. PMID 7496946 DOI: 10.1128/Cdli.1.2.202-205.1994  0.683
1994 Naab JK, Andersen R, Wadden T, Buckenmeyer PJ. 495 OXYGEN DILUTION VS. PREDICTED RESIDUAL LUNG VOLUME DETERMINATIONS ON CALCULATIONS OF BODY DENSITY IN OBESE WOMEN Medicine & Science in Sports & Exercise. 26: S88. DOI: 10.1249/00005768-199405001-00496  0.374
1994 Andersen RE, Miles DS, Wadden TA, Kendrick ZV, Bartlett SJ, Buckenmeyer P. 417 ACCURACY OF BIOELECTRIC IMPEDANCE ANALYZERS FOR BODY COMPOSITION ASSESSMENT IN OBESE WOMEN Medicine & Science in Sports & Exercise. 26: S74. DOI: 10.1249/00005768-199405001-00418  0.318
1993 Wadden TA. Treatment of obesity by moderate and severe caloric restriction. Results of clinical research trials. Annals of Internal Medicine. 119: 688-93. PMID 8363198 DOI: 10.7326/0003-4819-119-7_Part_2-199310011-00012  0.468
1993 Wadden TA, Foster GD, Letizia KA, Wilk JE. Metabolic, anthropometric, and psychological characteristics of obese binge eaters International Journal of Eating Disorders. 14: 17-25. PMID 8339095 DOI: 10.1002/1098-108X(199307)14:1<17::Aid-Eat2260140103>3.0.Co;2-L  0.68
1993 Buckenmeyer PJ, Wadden TA, Andersen R, Hawkins S, Ferrell M, Dzenis J, Meng J, Naab J. 315 EFFECT OF DIET AND EXERCISE REGIMENS ON BODY COMPOSITION OF OBESE WOMEN Medicine & Science in Sports & Exercise. 25: S57. DOI: 10.1249/00005768-199305001-00317  0.313
1993 Wadden TA. Etiology and treatment of obesity Current Opinion in Psychiatry. 6: 816-820. DOI: 10.1097/00001504-199312000-00015  0.324
1992 Stunkard AJ, Wadden TA. Psychological aspects of severe obesity. The American Journal of Clinical Nutrition. 55: 524S-532S. PMID 1733121 DOI: 10.1093/ajcn/55.2.524s  0.409
1992 Wadden TA, Foster GD, Wang J, Pierson RN, Yang MU, Moreland K, Stunkard AJ, Vanitallie TB. Clinical correlates of short- and long-term weight loss American Journal of Clinical Nutrition. 56. PMID 1615899 DOI: 10.1093/ajcn/56.1.271S  0.695
1992 Wadden TA, Bartlett S, Letizia KA, Foster GD, Stunkard AJ, Conill A. Relationship of dieting history to resting metabolic rate, body composition, eating behavior, and subsequent weight loss American Journal of Clinical Nutrition. 56. PMID 1615885 DOI: 10.1093/Ajcn/56.1.203S  0.69
1992 Wadden TA, Foster GD, Letizia KA, Stunkard AJ. A Multicenter Evaluation of a Proprietary Weight Reduction Program for the Treatment of Marked Obesity Archives of Internal Medicine. 152: 961-966. PMID 1580722 DOI: 10.1001/Archinte.1992.00400170051010  0.66
1992 Foster GD, Wadden TA, Peterson FJ, Letizia KA, Bartlett SJ. A controlled comparison of three very-low-calorie diets: Effects on weight, body composition, and symptoms American Journal of Clinical Nutrition. 55: 811-817. PMID 1550063 DOI: 10.1093/Ajcn/55.4.811  0.611
1992 Wadden TA, Foster GD, Letizia KA. Response of Obese Binge Eaters to Treatment by Behavior Therapy Combined With Very Low Calorie Diet Journal of Consulting and Clinical Psychology. 60: 808-811. PMID 1401399 DOI: 10.1037//0022-006X.60.5.808  0.68
1992 Wadden TA, Foster GD, Letizia KA. Response of obese binge eaters to treatment by behavior therapy combined with very low calorie diet. Journal of Consulting and Clinical Psychology. 60: 808-811. DOI: 10.1037/0022-006X.60.5.808  0.302
1992 Spitzer RL, Devlin M, Walsh BT, Hasin D, Wing R, Marcus M, Stunkard A, Wadden T, Yanovski S, Agras S, Mitchell J, Nonas C. Binge eating disorder: A multisite field trial of the diagnostic criteria International Journal of Eating Disorders. 11: 191-203. DOI: 10.1002/1098-108X(199204)11:3<191::Aid-Eat2260110302>3.0.Co;2-S  0.359
1991 Doherty JU, Wadden TA, Zuk L, Letizia KA, Foster GD, Day SC. Long-term evaluation of cardiac function in obese patients treated with a very-low-calorie diet: A controlled clinical study of patients without underlying cardiac disease American Journal of Clinical Nutrition. 53: 854-858. PMID 2008863 DOI: 10.1093/Ajcn/53.4.854  0.623
1991 Spiegel TA, Wadden TA, Foster GD. Objective measurement of eating rate during behavioral treatment of obesity Behavior Therapy. 22: 61-67. DOI: 10.1016/S0005-7894(05)80244-8  0.667
1991 Brownell KD, Wadden TA. The heterogeneity of obesity: fitting treatments to individuals Behavior Therapy. 22: 153-177. DOI: 10.1016/S0005-7894(05)80174-1  0.316
1991 Oettingen G, Wadden TA. Expectation, fantasy, and weight loss: Is the impact of positive thinking always positive? Cognitive Therapy and Research. 15: 167-175. DOI: 10.1007/Bf01173206  0.434
1991 Spitzer RL, Devlin MJ, Walsh BT, Hasin D, Wing R, Marcus MD, Stunkard A, Wadden T, Yanovski S, Agras S, Mitchell J, Nonas C. Binge eating disorder: To be or not to be in DSM-IV International Journal of Eating Disorders. 10: 627-629. DOI: 10.1002/1098-108X(199111)10:6<627::Aid-Eat2260100602>3.0.Co;2-4  0.733
1991 Wadden TA, Brown G, Foster GD, Linowitz JR. Salience of weight-related worries in adolescent males and females International Journal of Eating Disorders. 10: 407-414. DOI: 10.1002/1098-108X(199107)10:4<407::Aid-Eat2260100405>3.0.Co;2-V  0.636
1990 Stunkard AJ, Wadden TA. Restrained eating and human obesity. Nutrition Reviews. 48: 78-86; discussion 11. PMID 2407983 DOI: 10.1111/J.1753-4887.1990.TB02909.X  0.328
1990 Foster GD, Wadden TA, Feurer ID, Jennings AS, Stunkard AJ, Crosby LO, Ship J, Mullen JL. Controlled trial of the metabolic effects of a very-low-calorie diet: short- and long-term effects. The American Journal of Clinical Nutrition. 51: 167-72. PMID 2407096 DOI: 10.1093/Ajcn/51.2.167  0.659
1990 Wadden TA, Foster GD, Letizia KA, Mullen JL. Long-term Effects of Dieting on Resting Metabolic Rate in Obese Outpatients Jama: the Journal of the American Medical Association. 264: 707-711. PMID 2374273 DOI: 10.1001/Jama.1990.03450060053028  0.626
1990 Kendrick ZV, Foster GD, Wadden TA, Birdsall DP, Chesmel KD, Feldman DD. 513 EFFECT OF 8 TO 10 WEEKS OF A LOW CALORIE DIET ON STANDING AND AMBULATORY METABOLIC RATE Medicine & Science in Sports & Exercise. 22: S86. DOI: 10.1249/00005768-199004000-00513  0.524
1990 Wadden TA, Van Itallie TB, Blackburn GL. In Reply Jama: the Journal of the American Medical Association. 263: 2886-2887. DOI: 10.1001/Jama.1990.03440210035018  0.372
1989 Kramer FM, Stunkard AJ, Spiegel TA, Deren JJ, Velchik MG, Wadden TA, Marshall KA. Limited weight losses with a gastric balloon. Archives of Internal Medicine. 149: 411-3. PMID 2916886 DOI: 10.1001/archinte.1989.00390020113024  0.426
1988 Foster GD, Wadden TA, Mullen JL, Stunkard AJ, Wang J, Feurer ID, Pierson RN, Yang MU, Presta E, Van Itallie TB. Resting energy expenditure, body composition, and excess weight in the obese. Metabolism: Clinical and Experimental. 37: 467-72. PMID 3367789 DOI: 10.1016/0026-0495(88)90048-0  0.675
1988 Wadden TA, Stunkard AJ, Johnston FE, Wang J, Pierson RN, Van Itallie TB, Costello E, Peña M. Body fat deposition in adult obese women. II. Changes in fat distribution accompanying weight reduction. The American Journal of Clinical Nutrition. 47: 229-34. PMID 3341253 DOI: 10.1093/ajcn/47.2.229  0.423
1988 Johnston FE, Wadden TA, Stunkard AJ, Peña M, Wang J, Pierson RN, Van Itallie TB. Body fat deposition in adult obese women. I. Patterns of fat distribution. The American Journal of Clinical Nutrition. 47: 225-8. PMID 3341252 DOI: 10.1093/ajcn/47.2.225  0.325
1988 Wadden TA, Stunkard AJ, Liebschutz J. Three-year follow-up of the treatment of obesity by very low calorie diet, behavior therapy, and their combination. Journal of Consulting and Clinical Psychology. 56: 925-928. DOI: 10.1037/0022-006X.56.6.925  0.309
1987 Smoller JW, Wadden TA, Stunkard AJ. Dieting and depression: a critical review. Journal of Psychosomatic Research. 31: 429-40. PMID 3312589 DOI: 10.1016/0022-3999(87)90001-8  0.344
1987 Wadden TA, Stunkard AJ. Psychopathology and obesity. Annals of the New York Academy of Sciences. 499: 55-65. PMID 3300493 DOI: 10.1111/J.1749-6632.1987.TB36197.X  0.317
1986 Wadden TA, Stunkard AJ. Controlled trial of very low calorie diet, behavior therapy, and their combination in the treatment of obesity. Journal of Consulting and Clinical Psychology. 54: 482-488. DOI: 10.1037/0022-006X.54.4.482  0.302
1985 Wadden TA, Stunkard AJ. Social and psychological consequences of obesity. Annals of Internal Medicine. 103: 1062-7. PMID 4062126 DOI: 10.7326/0003-4819-103-6-1062  0.355
1985 Foster GD, Wadden TA, Brownell KD. Peer-Led Program for the Treatment and Prevention of Obesity in the Schools Journal of Consulting and Clinical Psychology. 53: 538-540. PMID 4031211 DOI: 10.1037/0022-006X.53.4.538  0.594
1985 Wadden TA. Childhood Obesity: A Comprehensive View Contemporary Psychology: a Journal of Reviews. 30: 188-189. DOI: 10.1037/023621  0.31
1984 Wadden TA, Foster GD, Brownell KD, Finley E. Self-concept in obese and normal-weight children Journal of Consulting and Clinical Psychology. 52: 1104-1105. PMID 6520282 DOI: 10.1037//0022-006X.52.6.1104  0.643
1984 Weinsier RL, Wadden TA, Ritenbaugh C, Harrison GG, Johnson FS, Wilmore JH. Recommended therapeutic guidelines for professional weight control programs American Journal of Clinical Nutrition. 40: 865-872. PMID 6486094  0.34
1984 Wadden TA. Mood changes associated with behavioral treatment of obesity. Journal of Psychosomatic Research. 28: 345-6. PMID 6481666 DOI: 10.1016/0022-3999(84)90057-6  0.306
1984 Wadden TA, Stunkard AJ, Brownell KD, Day SC. Treatment of obesity by behavior therapy and very low calorie diet: A pilot investigation Journal of Consulting and Clinical Psychology. 52: 692-694. PMID 6470296 DOI: 10.1037/0022-006X.52.4.692  0.333
1983 Wadden TA, Anderton CH, Foster GD, Love W. The Jenkins activity survey: does it measure psychopathology? Journal of Psychosomatic Research. 27: 321-325. PMID 6620209 DOI: 10.1016/0022-3999(83)90055-7  0.5
1981 Wadden TA, Flaxman J. Hypnosis and weight loss: a preliminary study. The International Journal of Clinical and Experimental Hypnosis. 29: 162-73. PMID 7275374 DOI: 10.1080/00207148108409156  0.393
1980 Wadden TA, Lucas RA. MMPI as a predictor of weight loss. Psychological Reports. 46: 984-6. PMID 7394116 DOI: 10.2466/pr0.1980.46.3.984  0.392
Show low-probability matches.